00092-0/asset/9cb4d176-26e3-4508-8aa1-ecdb4e971f8d/main.assets/gr3_lrg.jpg)
retatrutide type 2 diabetes phase 2 trial results 2024 Effects of on body composition in people with diabetes: a substudy of a 2, double-blind, parallel-group, placebo-controlled, randomised Triple hormone receptor agonist retatrutide
Description
Discuss with your healthcare team whether adjustment of other diabetes medications is needed
A good way to think about GLP-1s is like any other medication you take for your long-term health, be it to manage your thyroid, cholesterol, or hypertension
medRxiv , 2025.03.06.25323524 (2025).
The company projects revenue for the second quarter in the range of $680 million to $700 million, reflecting an uptick of 25% to 28% year over year
Beckers Hospital Review
K., & Ravi, R
